Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis

Sibbald, 1991, Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history, Thorax, 46, 895, 10.1136/thx.46.12.895 Bousquet, 2001, Allergic rhinitis and its impact on asthma, J Allergy Clin Immunol, 108, 1A, 10.1067/mai.2001.118891 Dykewicz, 1998, Diagnosis and management of rhinitis: parameter documents of the Joint Task Force on Practice Parameters in Allergy, Asthma, and Immunology, Ann Allergy Asthma Immunol, 81, 463, 10.1016/S1081-1206(10)63152-3 Christodoulopoulos, 2000, Molecular pathology of allergic disease. II: Upper airway disease, J Allergy Clin Immunol, 105, 211, 10.1016/S0091-6749(00)90068-X Howarth, 2002, Antihistamines in rhinoconjunctivitis, 179 Kreutner, 2000, Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist: 1st communication: receptor selectivity, antihistaminic activity, and anti-allergenic effects, Arzneimittelforschung/Drug Res, 50, 345 Geha, 2001, Desloratadine: a new, nonsedating, oral antihistamine, J Allergy Clin Immunol, 107, 752, 10.1067/mai.2001.114239 2002, Desloratadine: clinical pharmacokinetics of a novel H1-receptor antagonist, Clin Pharmacokinet, 41, 1 Meltzer, 2001, Efficacy and tolerability of once-daily 5 mg desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis: assessment during the spring and fall allergy seasons, Clin Drug Invest, 21, 25, 10.2165/00044011-200121010-00004 Nayak, 2001, Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis, Allergy, 56, 1077, 10.1034/j.1398-9995.2001.00082.x Bachert, 2001, Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis, Allergy, 56, 14, 10.1034/j.1398-9995.2001.00102.x Grossman, 1994, Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis, Ann Allergy, 73, 141 Mansmann, 1992, Efficacy and safety of cetirizine therapy in perennial allergic rhinitis, Ann Allergy, 68, 348 Murris-Espin, 1998, Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis, Ann Allergy Asthma Immunol, 80, 399, 10.1016/S1081-1206(10)62991-2 Bousquet, 1996, Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire, J Allergy Clin Immunol, 98, 309, 10.1016/S0091-6749(96)70155-0 Picado Valles, 1991, Ebastine in perennial allergic rhinitis, Ann Allergy, 67, 615 Bousquet, 1999, A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group, Allergy, 54, 562, 10.1034/j.1398-9995.1999.00984.x Ciprandi, 2001, Fexofenadine reduces nasal congestion in perennial allergic rhinitis, Allergy, 56, 1068, 10.1034/j.1398-9995.2001.00191.x Bruttmann, 1989, Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis, J Allergy Clin Immunol, 83, 411, 10.1016/0091-6749(89)90127-9 Frolund, 1990, A multicentre study of loratadine, clemastine and placebo in patients with perennial allergic rhinitis, Allergy, 45, 254, 10.1111/j.1398-9995.1990.tb00493.x Bellioni, 1996, Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis, Rhinology, 34, 101 Bachert, 1998, Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group, Allergy, 53, 969, 10.1111/j.1398-9995.1998.tb03798.x Wilson, 2000, Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow, Clin Exp Allergy, 30, 833, 10.1046/j.1365-2222.2000.00749.x